These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8642554)

  • 21. Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.
    Wentland MP; Lou R; Lu Q; Bu Y; VanAlstine MA; Cohen DJ; Bidlack JM
    Bioorg Med Chem Lett; 2009 Jan; 19(1):203-8. PubMed ID: 19027293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
    Bilsky EJ; Qian X; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues.
    Marastoni M; Guerrini R; Balboni G; Salvadori S; Fantin G; Fogagnolo M; Lazarus LH; Tomatis R
    Arzneimittelforschung; 1999 Jan; 49(1):6-12. PubMed ID: 10028372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potency.
    Spetea M; Greiner E; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2005 Jul; 48(15):5052-5. PubMed ID: 16033285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.
    Schütz J; Spetea M; Koch M; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2003 Sep; 46(19):4182-7. PubMed ID: 12954070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
    Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
    Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
    Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
    Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
    Qi JN; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1990 Aug; 254(2):683-9. PubMed ID: 2166801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
    Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
    J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
    Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Akuammine and dihydroakuammine, two indolomonoterpene alkaloids displaying affinity for opioid receptors.
    Lewin G; Le Ménez P; Rolland Y; Renouard A; Giesen-Crouse E
    J Nat Prod; 1992 Mar; 55(3):380-4. PubMed ID: 1317407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of quinolinopropellane derivatives with selective δ opioid receptor agonism.
    Nagase H; Nakajima R; Yamamoto N; Hirayama S; Iwai T; Nemoto T; Gouda H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2851-4. PubMed ID: 24835200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and analgesic activity of (-)-11 alpha-substituted 1,2,3,4,5,6-hexahydro-6 alpha,7-(methyleneoxy)-2,6-methano-3-benzazocines.
    Cittern PA; Kapoor VK; Parfitt RT
    J Med Chem; 1986 Oct; 29(10):1929-33. PubMed ID: 2876100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.